{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:45:08Z","timestamp":1789706708689,"version":"4.0.1"},"reference-count":206,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.imlet.2013.01.014","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T14:10:55Z","timestamp":1360591855000},"page":"10-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response"],"prefix":"10.1016","volume":"151","author":[{"given":"Dimitry A.","family":"Chistiakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Sobenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2013.01.014_bib0005","first-page":"775","article-title":"Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages","volume":"95","author":"Gerrity","year":"1979","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/0192623311430693","article-title":"Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression","volume":"40","author":"Peterson","year":"2012","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0020","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0025","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.106.633263","article-title":"Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule","volume":"114","author":"Gotsman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0030","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"120","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0035","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2174\/138945007783220588","article-title":"Cytokines as regulators of atherosclerosis in murine models","volume":"8","author":"Mallat","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.imlet.2013.01.014_bib0040","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","article-title":"The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib0050","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood."},{"key":"10.1016\/j.imlet.2013.01.014_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role of Scurfin in CD4+CD25+ regulatory T cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/icb.2010.137","article-title":"Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns","volume":"89","author":"Miyara","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1084\/jem.20030171","article-title":"CD4+CD25+ T cells regulate virus- specific primary and memory CD8+ T cell responses","volume":"198","author":"Suvas","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production","volume":"188","author":"Thornton","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0080","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X","article-title":"CD4+CD25+ regulatory T cells down-regulate co- stimulatory molecules on antigen-presenting cells","volume":"30","author":"Cederbom","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0085","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2013.01.014_bib0095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.01.014_bib0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2011.01010.x","article-title":"Clinical tolerance in allogeneic hematopoietic stem cell transplantation","volume":"241","author":"Roncarolo","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2013.01.014_bib0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2013.01.014_bib0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.187.4.571","article-title":"The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor","volume":"187","author":"Spencer","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1286-4579(01)01456-3","article-title":"Oral tolerance: immune mechanisms and the generation of Th3-type TGF-\u03b2-secreting regulatory cells","volume":"3","author":"Weiner","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.imlet.2013.01.014_bib0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4049\/jimmunol.178.1.179","article-title":"Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-\u03b2 T cell-transgenic mice","volume":"178","author":"Carrier","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.178.1.172","article-title":"Th3 cells in peripheral tolerance. II. TGF-\u03b2-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity","volume":"178","author":"Carrier","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.immuni.2006.07.011","article-title":"Transforming growth factor-\u03b2 controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms","volume":"25","author":"Li","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2013.01.014_bib0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","article-title":"T cell-produced transforming growth factor-\u03b21 controls T cell tolerance and regulates Th1- and Th17-cell differentiation","volume":"26","author":"Li","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2013.01.014_bib0150","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.172.2.834","article-title":"TGF-\u03b21 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice","volume":"172","author":"Nakamura","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/cimm.2000.1694","article-title":"Transforming growth factor-\u03b2 induces apoptosis in activated murine T cells through the activation of caspase 1-like protease","volume":"204","author":"Chung","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/clim.2001.5151","article-title":"Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-\u03b2: implications for dendritic cell immunization against cancer","volume":"102","author":"Lin","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0165","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00018-009-0026-2","article-title":"The development and function of regulatory T cells","volume":"66","author":"Workman","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.imlet.2013.01.014_bib0170","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0175","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-\u03b2 induces a regulatory phenotype in CD4+CD25\u2212 T cells through Foxp3 induction and down-regulation of Smad7","volume":"172","author":"Fantini","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0180","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-\u03b2 and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","article-title":"Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation","volume":"182","author":"Lal","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0190","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1371\/journal.pone.0001612","article-title":"FOXP3 promoter demethylation reveals the committed Treg population in humans","volume":"3","author":"Janson","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2013.01.014_bib0195","doi-asserted-by":"crossref","first-page":"14955","DOI":"10.1074\/jbc.M801123200","article-title":"STAT6 Inhibits TGF-\u03b21-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor","volume":"283","author":"Takaki","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2013.01.014_bib0200","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1371\/journal.pbio.0050329","article-title":"GATA3-driven Th2 responses inhibit TGF-\u03b21-induced FOXP3 expression and the formation of regulatory T cells","volume":"5","author":"Mantel","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2008.11.001","article-title":"IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1","volume":"122","author":"Hadjur","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.imlet.2013.01.014_bib0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0215","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2013.01.014_bib0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-\u03b2-induced Foxp3 inhibits Th17 cell differentiation by antagonizing ROR\u03b3t function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.01.014_bib0225","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imlet.2013.01.014_bib0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE\u2212\/\u2212 mice","volume":"49","author":"Xie","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2013.01.014_bib0240","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","article-title":"Cutting edge: regulatory T cells induce CD4+CD25\u2212Foxp3\u2212 T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-\u03b2","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2013.01.014_bib0245","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/mi.2008.51","article-title":"Regulatory T cells and the induction of IL-17","volume":"1","author":"Kitani","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0250","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.4049\/jimmunol.180.11.7112","article-title":"Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-\u03b2 are resistant to Th17 conversion by IL-6","volume":"180","author":"Zheng","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","article-title":"Natural and TGF-\u03b2-induced Foxp3+CD4+CD25+ regulatory T cells are not mirror images of each other","volume":"29","author":"Horwitz","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2013.01.014_bib0265","first-page":"527","article-title":"Ultrastructural identification of cells with dendritic cell appearance in atherosclerotic aorta of apolipoprotein E deficient mice","volume":"31","author":"Bobryshev","year":"1999","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0270","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.4049\/jimmunol.174.10.6509","article-title":"Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques","volume":"174","author":"Benagiano","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0275","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","article-title":"Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promoteatherosclerosis","volume":"125","author":"D\u00f6ring","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0280","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2009.01.002","article-title":"oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation","volume":"205","author":"Nickel","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0285","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fphys.2012.00230","article-title":"Plasmacytoid dendritic cells in atherosclerosis","volume":"3","author":"D\u00f6ring","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0290","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1172\/JCI61758","article-title":"Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis","volume":"122","author":"Koltsova","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2013.01.014_bib0295","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1073\/pnas.0711106105","article-title":"Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation","volume":"105","author":"Onishi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imlet.2013.01.014_bib0300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2011.01011.x","article-title":"Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28\/B7 family","volume":"241","author":"Bour-Jordan","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib0305","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/cmi.2011.62","article-title":"Trogocytosis of CD80 and CD86 by induced regulatory T cells","volume":"9","author":"Gu","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0315","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/eji.201141428","article-title":"Regulation of antigen-expressing dendritic cells by double negative regulatory T cells","volume":"41","author":"Gao","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2567.2006.02362.x","article-title":"Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+CD25+ regulatory T-cell-mediated suppression","volume":"118","author":"Oderup","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2013.01.014_bib0325","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.108.182428","article-title":"T-cell costimulation and coinhibition in atherosclerosis","volume":"103","author":"Gotsman","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0330","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2013.01.014_bib0335","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2011.09.014","article-title":"Flt3 signaling-dependent dendritic cells protect against atherosclerosis","volume":"35","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2013.01.014_bib0340","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+ CD25+ regulatory T cells","volume":"194","author":"Iellem","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0345","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.4049\/jimmunol.0804116","article-title":"Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4\/B7 and CCL22\/CCR4 interactions","volume":"183","author":"Onodera","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.CIR.104.2.197","article-title":"In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice","volume":"104","author":"Laurat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0355","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cytogfr.2008.11.003","article-title":"Interferon \u03b3: a master regulator of atherosclerosis","volume":"20","author":"McLaren","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib0360","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-\u03b3 potentiates atherosclerosis in apoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2013.01.014_bib0365","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-\u03b3 enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0370","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0375","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.178.1.592","article-title":"An inflammatory pathway of IFN-\u03b3 production in coronary atherosclerosis","volume":"178","author":"Ranjbaran","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0380","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI1216","article-title":"Hypercholesterolemia is associated with a T helper Th1\/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice","volume":"101","author":"Zhou","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2013.01.014_bib0385","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/01.ATV.0000245830.29764.84","article-title":"T cells in atherogenesis: for better or for worse","volume":"26","author":"Robertson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0390","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/01.CIR.103.21.2610","article-title":"T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia","volume":"103","author":"Huber","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0395","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor\u2212\/\u2212 mice","volume":"22","author":"King","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0400","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0405","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","article-title":"The role of natural antibodies in atherogenesis","volume":"46","author":"Binder","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0410","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1517\/14712598.2011.610789","article-title":"Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus","volume":"11","author":"Miller","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.imlet.2013.01.014_bib0415","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2008.10.017","article-title":"Hypercholesterolemia leads to elevated TGF-\u03b21 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice","volume":"204","author":"Zhou","year":"2009","journal-title":"Atheroslerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0420","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0425","first-page":"37","article-title":"T lymphocyte co-signaling pathways of the B7-CD28 family","volume":"1","author":"Wang","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0430","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0435","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","article-title":"Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes","volume":"90","author":"Pinderski","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0440","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/CIRCULATIONAHA.107.699470","article-title":"Measles virus nucleoprotein induces a regulatory immune response and reduces atherosclerosis in mice","volume":"116","author":"Ait-Oufella","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0445","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2011.04.029","article-title":"Differential effects of regulatory T cells on the initiation and regression of atherosclerosis","volume":"218","author":"Foks","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0450","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH09-01-0029","article-title":"The multi-functionality of CD40L and its receptor CD40 in atherosclerosis","volume":"102","author":"Lievens","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.imlet.2013.01.014_bib0455","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.01.014_bib0460","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1398-9995.2008.01839.x","article-title":"Inhibition of allergic responses by CD40 gene silencing","volume":"64","author":"Suzuki","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.imlet.2013.01.014_bib0465","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0470","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0475","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 cells in immunity to Candida albicans","volume":"11","author":"Hern\u00e1ndez-Santos","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imlet.2013.01.014_bib0480","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2008.12.032","article-title":"Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet","volume":"47","author":"Pejnovic","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0490","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0495","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/14017431.2010.491123","article-title":"Increased Th17 cells in coronary artery disease are associated with neutrophilic inflammation","volume":"45","author":"Wang","year":"2011","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.imlet.2013.01.014_bib0500","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2011.03.043","article-title":"Activation of Th17\/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome","volume":"217","author":"Zhao","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0505","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2011.12.026","article-title":"Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication","volume":"221","author":"Liu","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0510","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2011.07.003","article-title":"IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome","volume":"141","author":"Zhu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0515","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-\u03b3 are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0520","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000317400","article-title":"Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species","volume":"48","author":"Pietrowski","year":"2011","journal-title":"J Vasc Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0525","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/S0024-3205(03)00186-3","article-title":"NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells","volume":"72","author":"Lee","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.imlet.2013.01.014_bib0530","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.atherosclerosis.2010.07.014","article-title":"Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe\u2212\/\u2212 mice","volume":"212","author":"Dun\u00e9r","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0535","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.110.221069","article-title":"Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis","volume":"107","author":"Dart","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0540","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.30220","article-title":"Exacerbation of type II collagen-induced arthritis in apolipoprotein E-deficient mice in association with the expansion of Th1 and Th17 cells","volume":"63","author":"Postigo","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2013.01.014_bib0545","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0550","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0555","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0560","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0565","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.cca.2010.08.013","article-title":"The Th17\/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction","volume":"411","author":"Li","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.imlet.2013.01.014_bib0570","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0575","doi-asserted-by":"crossref","first-page":"17003","DOI":"10.1074\/jbc.M801286200","article-title":"Foxp3 inhibits ROR\u03b3t-mediated IL-17A mRNA transcription through direct interaction with ROR\u03b3t","volume":"283","author":"Ichiyama","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2013.01.014_bib0580","doi-asserted-by":"crossref","unstructured":"Vocanson M, Rozieres A, Hennino A, Poyet G, Gaillard V, Renaudineau S, et al. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17\/TH1 and regulatory T cells. J Allergy Clin Immunol 126:280\u20139, 289.e1\u20137.","DOI":"10.1016\/j.jaci.2010.05.022"},{"key":"10.1016\/j.imlet.2013.01.014_bib0585","article-title":"IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease","volume":"129","author":"Whitehead","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0590","first-page":"53","article-title":"CD4+Foxp3+ Treg and its ICOS+ subsets in patients with myocardial infarction","volume":"9","author":"Ghourbani Gazar","year":"2012","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0595","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.imlet.2013.01.014_bib0600","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/mi.2012.4","article-title":"Oral tolerance to food protein","volume":"5","author":"Pabst","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0605","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.106.615609","article-title":"Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis","volume":"114","author":"van Puijvelde","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0610","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/ATVBAHA.109.202671","article-title":"Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis","volume":"30","author":"Klingenberg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0615","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2796.2010.02311.x","article-title":"Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine","volume":"269","author":"Wigren","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0620","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0735-1097(02)02135-6","article-title":"Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions","volume":"40","author":"Harats","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0625","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.0000029750.99462.30","article-title":"Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice","volume":"106","author":"Maron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0630","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/ATVBAHA.107.151274","article-title":"Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis","volume":"27","author":"van Puijvelde","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0635","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardiores.2004.01.028","article-title":"Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with \u03b22-glycoprotein I","volume":"62","author":"George","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0640","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.4049\/jimmunol.177.11.7634","article-title":"Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3\u2212CD25\u2212CD4+ regulatory T cells","volume":"177","author":"Sun","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0645","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0891-5849(92)90181-F","article-title":"The role of lipid peroxidation and antioxidants in the oxidative modification of LDL","volume":"13","author":"Esterbauer","year":"1992","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0650","series-title":"Biochemistry of Lipids, Lipoproteins and Membranes","first-page":"485","article-title":"Lipoprotein structure","author":"Jonas","year":"2008"},{"key":"10.1016\/j.imlet.2013.01.014_bib0655","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation","volume":"51","author":"Brunzell","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0660","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0026-0495(96)90005-0","article-title":"Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein","volume":"45","author":"Aviram","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.imlet.2013.01.014_bib0665","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1172\/JCI112371","article-title":"Superoxide mediated modification of low density lipoprotein by human arterial smooth muscle cells","volume":"77","author":"Heinecke","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2013.01.014_bib0670","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0022-2275(20)35347-5","article-title":"Oxidation of low density lipoprotein by thiols: superoxide dependent and independent mechanisms","volume":"34","author":"Heinecke","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0675","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1042\/bst0210358","article-title":"Peroxynitrite and atherosclerosis","volume":"21","author":"Hogg","year":"1993","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.imlet.2013.01.014_bib0680","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00019501-199403000-00004","article-title":"Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis","volume":"5","author":"Heinecke","year":"1994","journal-title":"Coronary Artery Dis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0685","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","article-title":"Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N EngI J Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0690","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/abio.1993.1389","article-title":"A method for defining stages of LDL oxidation by separation of cholesterol and cholesterol ester oxidation products using high pressure liquid chromatography","volume":"213","author":"Kritharides","year":"1993","journal-title":"Anal Biochem"},{"key":"10.1016\/j.imlet.2013.01.014_bib0695","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-2275(20)38678-8","article-title":"Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes","volume":"28","author":"Esterbauer","year":"1987","journal-title":"J Lipid Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0700","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.ATV.9.4.538","article-title":"Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages","volume":"9","author":"Hoff","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0705","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7827(92)90006-5","article-title":"Role of oxidized low density lipoprotein in atherogenesis","volume":"31","author":"Parthasarathy","year":"1992","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0710","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(98)00153-1","article-title":"Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury","volume":"141","author":"Hill","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0715","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cvr\/cvp338","article-title":"Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice","volume":"85","author":"Habets","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0720","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.freeradbiomed.2011.05.029","article-title":"Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a","volume":"51","author":"Veneskoski","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0725","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.112.099044","article-title":"Cytokine therapy with interleukin-2\/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis","volume":"126","author":"Dinh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0730","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm1408","article-title":"Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25\u2212LAP+ T cells","volume":"12","author":"Ochi","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0735","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2337\/db06-1632","article-title":"Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody","volume":"56","author":"Ishikawa","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2013.01.014_bib0740","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10875-009-9323-7","article-title":"Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells","volume":"30","author":"Ilan","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0745","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/mabs.3.1.13895","article-title":"Antibody-based therapeutics to watch in 2011","volume":"3","author":"Reichert","year":"2011","journal-title":"Mabs"},{"key":"10.1016\/j.imlet.2013.01.014_bib0750","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.106.627430","article-title":"Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice","volume":"114","author":"Steffens","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0755","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.4049\/jimmunol.181.9.6038","article-title":"Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+CD25\u2212LAP+ regulatory T cell and is associated with down-regulation of IL-17+CD4+ICOS+CXCR5+ follicular helper T cells","volume":"181","author":"Wu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0760","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.4049\/jimmunol.180.11.7327","article-title":"Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGF-\u03b2-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis","volume":"180","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0765","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcp.21001","article-title":"The regulation of Foxp3 expression in regulatory CD4+CD25+ T cells: multiple pathways on the road","volume":"211","author":"Zhang","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0770","doi-asserted-by":"crossref","unstructured":"Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1\/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324:23-33.","DOI":"10.1124\/jpet.107.127209"},{"key":"10.1016\/j.imlet.2013.01.014_bib0775","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0780","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0785","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","article-title":"Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3","volume":"106","author":"Penna","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2013.01.014_bib0790","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.4049\/jimmunol.179.9.6273","article-title":"Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes","volume":"179","author":"Gorman","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0795","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/dmrr.1276","article-title":"The effect of vitamin D supplementation on peripheral regulatory T cells and \u03b2 cell function in healthy humans: a randomized controlled trial","volume":"27","author":"Bock","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib0800","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/ATVBAHA.110.215459","article-title":"Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions","volume":"30","author":"Takeda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0805","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0810","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2119\/molmed.2011.00471","article-title":"Statins induce the accumulation of regulatory T cells in atherosclerotic plaque","volume":"18","author":"Meng","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib0815","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.atherosclerosis.2009.03.028","article-title":"Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall","volume":"206","author":"Kajimoto","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0820","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","article-title":"The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells","volume":"197","author":"Mausner-Fainberg","year":"2008","journal-title":"Atheroslerosis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0825","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/FJC.0b013e318211d016","article-title":"Effect of oral atorvastatin on CD4+CD25+ regulatory T cells, FoxP3 expression, and prognosis in patients with ST-segment elevated myocardial infarction before primary percutaneous coronary intervention","volume":"57","author":"Zhang","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0830","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0835","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0840","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/CIRCULATIONAHA.106.641407","article-title":"FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"115","author":"Nofer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2013.01.014_bib0845","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.ATV.0000254679.42583.88","article-title":"The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Keul","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0850","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/039463201202500209","article-title":"Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice","volume":"25","author":"Huang","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0855","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4155\/fmc.12.25","article-title":"Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis","volume":"4","author":"Chiba","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.imlet.2013.01.014_bib0860","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clim.2008.07.031","article-title":"Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid","volume":"129","author":"Li","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0865","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trim.2012.09.003","article-title":"Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR+-Treg-cells in transplanted patients","volume":"27","author":"Seissler","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0870","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.trim.2008.06.004","article-title":"Differentially modulated dendritic cells induce regulatory T cells with different characteristics","volume":"19","author":"Roelen","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0875","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0880","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/157016111796642689","article-title":"Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage","volume":"9","author":"Waanders","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0885","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0890","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","article-title":"T regulatory lymphocytes prevent aldosterone-induced vascular injury","volume":"59","author":"Kasal","year":"2012","journal-title":"Hypertension"},{"issue":"5 Suppl.","key":"10.1016\/j.imlet.2013.01.014_bib0895","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1590\/S0021-75572007000700007","article-title":"Glucocorticoid therapy: minimizing side effects","volume":"83","author":"Longui","year":"2007","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.imlet.2013.01.014_bib0900","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cyto.2006.05.007","article-title":"Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: a possible role for interleukin-6","volume":"34","author":"Tous","year":"2006","journal-title":"Cytokine"},{"issue":"188","key":"10.1016\/j.imlet.2013.01.014_bib0905","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-540-71029-5_9","article-title":"Aspirin and the induction of tolerance by dendritic cells","author":"Buckland","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0910","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1600-6143.2006.01450.x","article-title":"Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells","volume":"6","author":"Buckland","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.imlet.2013.01.014_bib0915","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2012.10.005","article-title":"Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice","volume":"697","author":"Zhang","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0920","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/ATVBAHA.112.300627","article-title":"Hydrogen sulfide releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo","volume":"32","author":"Pircher","year":"2012","journal-title":"Arherioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0925","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bcp.2005.04.044","article-title":"Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosisin apoE-null mice","volume":"70","author":"Burleigh","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0930","first-page":"476","article-title":"Antiatherosclerotic activity of ibuprofen, a non-selective COX inhibitor\u2014an animal study","volume":"46","author":"Dabhi","year":"2008","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0935","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/rheumatology\/kep225","article-title":"Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation","volume":"49","author":"Padol","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2013.01.014_bib0940","first-page":"347","article-title":"Cardiovascular complications of non-steroidal anti-inflammatory drugs","volume":"35","author":"Fosslien","year":"2005","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.imlet.2013.01.014_bib0945","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/CJI.0b013e31818ac2f7","article-title":"The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells","volume":"32","author":"Lee","year":"2009","journal-title":"J Immunother"},{"key":"10.1016\/j.imlet.2013.01.014_bib0950","doi-asserted-by":"crossref","first-page":"503028","DOI":"10.1155\/2011\/503028","article-title":"Methotrexate in atherogenesis and cholesterol metabolism","volume":"2011","author":"Coomes","year":"2011","journal-title":"Cholesterol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0955","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/FJC.0b013e318241c385","article-title":"Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits","volume":"59","author":"Bulgarelli","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.imlet.2013.01.014_bib0960","doi-asserted-by":"crossref","unstructured":"Oh JS, Kim YG, Lee SG, So MW, Choi SW, Lee CK, et al. The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells. Rheumatol Int, in press. http:\/\/dx.doi.org\/10.1007\/s00296-012-2365-9.","DOI":"10.1007\/s00296-012-2365-9"},{"key":"10.1016\/j.imlet.2013.01.014_bib0965","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00011-012-0520-0","article-title":"Combined use of etanercept and MTX restores CD4+\/CD8+ ratio and Tregs in spleen and thymus in collagen-induced arthritis","volume":"61","author":"Huang","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.imlet.2013.01.014_bib0970","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000289201","article-title":"TNF-\u03b1: an activator of CD4+FoxP3+TNFR2+ regulatory T cells","volume":"11","author":"Chen","year":"2010","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.imlet.2013.01.014_bib0975","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2013.01.014_bib0980","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2567.2008.02839.x","article-title":"Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease","volume":"125","author":"Ricciardelli","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2013.01.014_bib0985","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ibd.21308","article-title":"Therapy with anti-TNF\u03b1 antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases","volume":"17","author":"Boschetti","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.imlet.2013.01.014_bib0990","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/eye.2011.320","article-title":"Adalimumab specifically induces CD3+CD4+CD25highFoxp3+CD127\u2212 T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study","volume":"26","author":"Calleja","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.imlet.2013.01.014_bib0995","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.autrev.2010.07.018","article-title":"The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases","volume":"9","author":"Atzeni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.imlet.2013.01.014_bib1000","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1759720X11436239","article-title":"Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity","volume":"4","author":"Marks","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.imlet.2013.01.014_bib1005","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3899\/jrheum.120541","article-title":"Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis\u2014a randomized trial","volume":"39","author":"Tam","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2013.01.014_bib1010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nri2335","article-title":"Dendritic cells in intestinal immune regulation","volume":"8","author":"Coombes","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.imlet.2013.01.014_bib1015","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20070602","article-title":"Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid","volume":"204","author":"Sun","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2013.01.014_bib1020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature07240","article-title":"ATP drives lamina propria TH17 cell differentiation","volume":"455","author":"Atarashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.01.014_bib1025","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/ATVBAHA.112.251314","article-title":"Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Macritchie","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.imlet.2013.01.014_bib1030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1476-5381.2010.00922.x","article-title":"Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells","volume":"161","author":"Eastwood","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247813000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247813000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:33:45Z","timestamp":1759044825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247813000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":206,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0165247813000278"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2013.01.014","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2013.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}